Prosensa/BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders.

Research focus: Exon Skipping

Status: The clinical program has been halted.

Website: http://www.biomarin.com

Venture philanthropy timeline and case study